Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.47 USD | 0.00% | +13.95% | +38.68% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 8M | Capitalization | 84.9M |
---|---|---|---|---|---|
Net income 2024 * | -38M | Net income 2025 * | -37M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 10.6 x |
P/E ratio 2024 * |
-2.1
x | P/E ratio 2025 * |
-2.12
x | Employees | 16 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.73% |
Latest transcript on SELLAS Life Sciences Group, Inc.
1 week | +13.95% | ||
Current month | +18.55% | ||
1 month | +8.09% | ||
3 months | +90.91% | ||
6 months | +59.66% | ||
Current year | +38.68% |
Managers | Title | Age | Since |
---|---|---|---|
Angelos Stergiou
FOU | Founder | 48 | 06-04-02 |
John Burns
DFI | Director of Finance/CFO | 39 | 13-04-30 |
Andrew Elnatan
LAW | General Counsel | - | 23-01-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 17-12-28 | |
David Scheinberg
BRD | Director/Board Member | 68 | 17-11-30 |
John Varian
BRD | Director/Board Member | 64 | 17-12-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 1.47 | 0.00% | 1,289,376 |
24-05-15 | 1.47 | +7.30% | 1,518,452 |
24-05-14 | 1.37 | 0.00% | 868,571 |
24-05-13 | 1.37 | +1.11% | 679,379 |
24-05-10 | 1.355 | +5.04% | 1,406,261 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.68% | 84.9M | |
+8.29% | 114B | |
+10.21% | 104B | |
+0.41% | 22.28B | |
-11.90% | 22.41B | |
-5.99% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- SLS Stock